Epigenetics/epigenomics of triterpenoids in cancer prevention and in health
Authors:
- 1 May 2020
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 175, 113890
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 138 references indexed in Scilit:
- miR-200a Regulates Nrf2 Activation by Targeting Keap1 mRNA in Breast Cancer CellsJournal of Biological Chemistry, 2011
- An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transitionMolecular Biology of the Cell, 2011
- Synthetic triterpenoid CDDO prevents the progression and metastasis of prostate cancer in TRAMP mice by inhibiting survival signalingCarcinogenesis, 2011
- The Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic-acid Methyl Ester Has Potent Anti-diabetic Effects in Diet-induced Diabetic Mice and Lepr MiceJournal of Biological Chemistry, 2010
- Epigenetics: Definition, Mechanisms and Clinical PerspectiveSeminars in Reproductive Medicine, 2009
- Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated miceCarcinogenesis, 2009
- Perceptions of epigeneticsNature, 2007
- Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancerNature Reviews Cancer, 2007
- The Consensus Coding Sequences of Human Breast and Colorectal CancersScience, 2006
- Cancer chemoprevention with dietary phytochemicalsNature Reviews Cancer, 2003